Cutler Group’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-42
Closed -$2K 6493
2021
Q2
$2K Sell
42
-70
-63% -$8.12K ﹤0.01% 5121
2021
Q1
$3K Buy
+112
New +$15.7K ﹤0.01% 4794

Other funds holding QNTM

Cutler Group's QNTM Position: Q1 2022 in Review

Cutler Group sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q1 2022, closing a stake of 3 shares.

Cutler Group first reported a position in QNTM in Q3 2020 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 19 funds tracked by Wall St. Rank hold QNTM as of Q1 2022.

  • Cutler Group reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q1 2022 after selling out during the quarter.
  • Cutler Group sold 3 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2022.
  • Cutler Group first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2020 and held it in 3 quarters.
  • Cutler Group's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $1K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.